Skin Cancer: Neoplasms of the skin

It is estimated that 1 in 52 men and 1 in 77 women in the US will be diagnosed with melanoma in their lifetime. Despite the fact that melanoma is one of the most rapidly increasing forms of human cancer, new treatments have been slow in developing and the mortality rate continues to rise. We now know that there are several well-defined risk factors for this form of cancer.

Our report contains quantitative and qualitative analytical content, covering the present and future of the global cancer drugs market. Although our report is market-centered, we include medical and technical information. We include analyses of under-met market needs from the present looking forward. GMR Data forecast that Avastin will reach its financial peak by 2018 before losing its patent exclusivity in 2019. The drug is also set to benefit from a potential combination therapy, with EGFL7, for the treatment of colorectal and lung cancer, similar to that of Herceptin and Perjeta.

  • Pediatric melanoma
  • Skin cancers after organ transplantation
  • Non-melanoma skin cancer
  • Human melanoma
  • Cutaneous melanoma

Related Conference of Skin Cancer: Neoplasms of the skin

April 10-11, 2025

27th World Dermatology and Aesthetic Congress

Dubai, UAE
May 20-21, 2025

30th International Conference on Dermatology & Skin Care

Zurich, Switzerland
June 12-13, 2025

8th World Cosmetic and Dermatology Congress

London, UK
July 28-29, 2025

25th European Dermatology Congress

Paris, France
August 20-21, 2025

26th World Dermatology Congress

Paris, France
August 21-22, 2025

8th International Dermatology and Cosmetology Congress

Dublin, Ireland
September 15-16, 2025

24th International Conference on Dermatology and Skin Care Sciences

Aix-en-Provence, France

Skin Cancer: Neoplasms of the skin Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in